Together we will beat cancer

Donate

‘Cutting edge’ CAR T cell immunotherapy approved in England. But is the NHS ready?

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

Read More

From cancer evolution to targeting faulty genetics – our new fellows

Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.

Read More

Not actually a pain in the neck: how cancer took me from patient to psychiatrist

For World Health Day a cancer survivor shares his story about tackling mental health issues after treatment, and how it inspired a career change.

Read More

A lasting immune impression could boost blood cancer treatments

Our researchers may have found a new way to tap into the power of the immune system to fight cancer. Read about their work

Read More

Sellafield, radiation and childhood cancer – shedding light on cancer clusters near nuclear sites

A new report confirms that radiation from a nuclear plant wasn’t to blame for a spike in childhood leukaemia in north-west England – so what was?

Read More

How a little known organ could protect people who’ve had stem cell transplants

Our Stand Up To Cancer-funded researchers in Birmingham are turning their immune cell knowledge into ways to tackle infection after treatment.

Read More

Meet our new research fellows 2016

Find out how our new up and coming researchers plan to tackle some of the big scientific questions in cancer.

Read More

A legacy of research – Beatrice and Harry’s story

Right now, people are doing amazing things to support our life-saving research. From flipping pancakes to pedalling for victory –…

Read More

Gene editing technology could help engineer better cancer targeting immune cells

We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells.

Read More

Immunotherapy cancer ‘cure’ headlines distract from fascinating science

We explore today’s headlines about new US research on immunotherapy for blood cancers.

Read More